바이오인

BioMarket Trends: Pediatric Market Offers Multiple Opportunities

 

Paucity of Therapeutics for Children

Bruce Carlson

 

Long underserved and undervalued, the pediatric population is beginning to emerge as an opportunity area for prescription pharmaceuticals. As a new, uncertain era opens for the pharmaceutical industry—one with fewer obvious blockbuster products and more emphasis on portfolio optimization—companies are beginning to see that “children are the future” is not just a cliché.